DDMAC Issues Untitled Letter to Alcon for Misleading Travatan Promotion

Drug Industry Daily
KEYWORDS Advertising / FDA
A A

The FDA’s advertising division has issued Alcon an untitled letter for disseminating a flash card promotion that contains unsubstantiated comparison and superiority claims for its ophthalmic solution Travatan.

To View This Article:

Login

Subscribe To Drug Industry Daily